Congenital Heart Disease

Cardiologists must emphasize the benefits of lifelong care early for adolescents and emerging adults with congenital heart disease, working with families to provide support based on individual needs, according to a new scientific statement.

On Feb. 1, the first-in-human implantation of a novel miniaturized stent for infants and small children that can be expanded as they grew was performed at Children’s Hospital Los Angeles.

The Children’s Heart Foundation announced it funded more than $1 million in congenital heart defects research and scientific collaborations in 2021.

At 10 years, transcatheter pulmonary valve replacement provided sustained symptomatic and hemodynamic improvement in most patients with complex congenital heart disease, data from the Melody investigational device exemption trial indicated.

Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for patients with severe pulmonary regurgitation.

Extracardiac anomalies, including structural brain anomalies, were frequently detected on fetal MRI among fetuses with various forms of congenital heart disease, researchers reported.

In a study published in the European Heart Journal, researchers found low maternal mortality among pregnant women with congenital heart disease in highly developed health care systems.

Renal replacement therapy was insufficient for protein delivery in critically ill children with congenital heart disease, according to a single-center retrospective cohort study in Journal of Renal Nutrition.

Researchers in Sweden reported that atherosclerosis was present in more than 40% of individuals aged 50 to 64 years with no known CHD.

Women with high blood lipid levels during early pregnancy face higher risks of having children with congenital heart disease, according to a study published by Acta Obstetricia et Gynecologica Scandinavica.